Stem cell virus therapy takes on deadly brain tumors
NCT ID NCT06169280
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This early-phase study tests whether giving multiple doses of a special virus carried by neural stem cells is safe and possible for people with newly diagnosed high-grade glioma. Participants receive the therapy directly into the brain before, during, and after standard radiation and chemotherapy. The study involves 20 adults and focuses on safety, tumor response, survival, and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA, MALIGNANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tracer that hunts unstable iron light up hidden tumors?
- Targeted antibody may boost brain cancer treatment after incomplete surgery
- Experimental brain tumor cocktail targets recurrent glioma
- Blood tests could reveal hidden clues in aggressive brain cancer
- Brain cancer breakthrough? new trial delivers drug straight to tumor
- Surgical flap may open door to better brain tumor treatment